[Pre-Aug 2018] IMSCAR

  1. 2003
  2. Cyhoeddwyd

    The development of COMRADE - a patient-based outcome measure to evaluate the effectiveness of risk communication and treatment decision making in consultations

    Russell, I. T., Edwards, A., Elwyn, G., Hood, K., Robling, M., Atwell, C., Holmes-Rovner, M., Kinnersley, P., Houston, H. & Russell, I., 1 Gorff 2003, Yn: Patient Education and Counseling. 50, 3, t. 311-322

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  3. Cyhoeddwyd
  4. Cyhoeddwyd

    Resilience in Older Age.

    Windle, G., 5 Gorff 2003.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  5. Cyhoeddwyd
  6. Cyhoeddwyd

    Cluster randomised trial of risk communication to enhance informed uptake of cervical screening.

    Russell, I. T., Holloway, R. M., Wilkinson, C., Peters, T. J., Russell, I., Cohen, D., Hale, J., Rogers, C. & Lewis, H., 1 Awst 2003, Yn: British Journal of General Practice. 53, 493, t. 620-625

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  7. Cyhoeddwyd

    Older People in Wales, their transport and mobility; A Literature Review.

    Windle, G. & Burholt, V., 1 Awst 2003, Yn: Quality in Ageing: Policy, Practice and Research. 4, 2, t. 28-35

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  8. Cyhoeddwyd

    UK Back Pain Exercise And Manipulation (UK BEAM) trial - national randomised trial of physical treatments for back pain in primary care: objectives, design and interventions [ISRCTN32683578]

    Russell, I. T., Russell, I., Vickers, M., Moffett, J. K., Underwood, M. R., Brealey, S., Burton, K., Coulton, S., Farrin, A., Garratt, A., Harvey, E., Letley, L., Martin, J., Torgerson, D., Whyte, K. & Williams, M., 1 Awst 2003, Yn: BMC Health Services Research. 3, t. 16

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  9. Cyhoeddwyd

    Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?

    Hughes, D., Hughes, D. A. & Pirmohamed, M., 1 Medi 2003.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  10. Cyhoeddwyd

    Antidepressants and suicide: risk-benefit conundrums

    Healy, D. & Whitaker, C. J., 1 Medi 2003, Yn: Journal of Psychiatry and Neuroscience. 28, 5, t. 331-337

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  11. Cyhoeddwyd

    Can randomised trials rely on existing electronic data: a feasibility study to explore the value of routine data in health technology assessment.

    Williams, J. G., Cheung, W. Y., Cohen, D. R., Hutchings, H. A., Longo, M. F. & Russell, I. T., 1 Medi 2003, Yn: Health Technology Assessment. 7, 26, t. 1-136

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  12. Cyhoeddwyd

    Modelling changes in first line antimalarial therapy

    Hughes, D. & Hughes, D. A., 1 Medi 2003.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  13. Cyhoeddwyd

    Housing, Health and Service Use: Evidence from Wales.

    Windle, G., Edwards, R. T. & Burholt, V., 14 Medi 2003.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  14. Cyhoeddwyd

    Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?

    Hughes, D., Hughes, D. A. & Pirmohamed, M., 1 Tach 2003.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  15. Cyhoeddwyd

    Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?

    Hughes, D., Hughes, D. A. & Pirmohamed, M., 1 Tach 2003, Yn: Value in Health. 6, 6, t. 749

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  16. Cyhoeddwyd

    Cost-utility analysis of on demand rabeprazole and esomeprazole for symptomatic gastro oesophageal reflux disease

    Hughes, D., Hughes, D. A. & Dubois, D., 1 Tach 2003, Yn: Value in Health. 6, 6, t. 613

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  17. Cyhoeddwyd

    Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease

    Hughes, D. & Hughes, D. A., 1 Tach 2003.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  18. Cyhoeddwyd

    Cost-utility analysis of on-demand rabeprazole and esomeprazole for non-erosive reflux disease

    Hughes, D. & Hughes, D. A., 1 Tach 2003.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  19. Cyhoeddwyd

    Estimating the marginal value of ‘better’ research output: ‘designed’ v ‘routine’ data in randomised trials.

    Cohen, D., Longo, M. F., Williams, J., Cheung, W. Y., Hutchings, H. & Russell, I. T., 1 Tach 2003, Yn: Health Economics. 12, 11, t. 959-974

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  20. Cyhoeddwyd

    Use of PK-PD modelling to predict the impact of non-compliance

    Hughes, D. & Hughes, D. A., 1 Tach 2003.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  21. Cyhoeddwyd

    Randomized osteopathic manipulation study (ROMANS): pragmatic trial for spinal pain in primary care

    Williams, N. H., Wilkinson, C., Russell, I., Edwards, R. T., Hibbs, R., Linck, P. & Muntz, R., Rhag 2003, Yn: Family Practice. 20, 6, t. 662-669 8 t.

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  22. Cyhoeddwyd

    A matter of preference.

    Burholt, V. & Windle, G., 1 Rhag 2003, Yn: Professional Social Work. t. 18-19

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  23. Cyhoeddwyd

    Drug compliance and pharmaceconomics

    Hughes, D. & Hughes, D. A., 1 Rhag 2003.

    Allbwn ymchwil: Cyfraniad at gynhadleddPapur

  24. 2004
  25. Cyhoeddwyd

    Approaches to pharmacoeconomic analysis

    Hughes, D., Hughes, D. A., Walley, T. (gol.), Haycox, A. (gol.), Boland, A. (gol.) & Breckenridge, A. (gol.), 1 Ion 2004, Pharmacoeconomics. 2004 gol. Adis International, t. 101-126

    Allbwn ymchwil: Pennod mewn Llyfr/Adroddiad/Trafodion CynhadleddPennod

  26. Cyhoeddwyd

    Clinical Pharmacology: Special safety considerations in drug development and pharmacovigilance.

    Hughes, D., Atuah, K. N., Hughes, D. A. & Pirmohamed, M., 1 Ion 2004, Yn: Drug Safety. 27, 8, t. 535-554

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  27. Cyhoeddwyd

    Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.

    Hughes, D., Hughes, D. A. & Dubois, D., 1 Ion 2004, Yn: Pharmacoeconomics. 22, 16, t. 1047-1059

    Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid